AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

10,782.00p
   
  • Change Today:
      82.00p
  • 52 Week High: 13,276.00
  • 52 Week Low: 9,667.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.66m
  • Volume: 1,034,912
  • Market Cap: £167,192m
  • RiskGrade: 123

Latest ShareCast News

AstraZeneca's Calquence receives European Commission approval

By Iain Gilbert

Date: Friday 06 Jun 2025

(Sharecast News) - Drugmaker AstraZeneca said on Friday that it had received approval from the European Commission for fixed-duration regimens of its chronic lymphocytic leukaemia candidate Calquence in a first-line setting.

EU recommends AstraZeneca bladder cancer treatment for approval

By Benjamin Chiou

Date: Tuesday 27 May 2025

(Sharecast News) - EU regulators have recommended AstraZeneca's Imfinzi for approval in the treatment muscle-invasive bladder cancer (MIBC).

London close: Stocks finish choppy week in the black

By Josh White

Date: Friday 16 May 2025

(Sharecast News) - London equities ended the week higher on Friday, supported by gains in pharmaceutical and energy stocks.

London close: Stocks rally on US-China tariff deal 12-May-2025 ShareCast
Pharma stocks slide as Trump threatens price cut... 12-May-2025 ShareCast
Sunday newspaper round-up: US-China, Aerospace, ... 11-May-2025 ShareCast
London close: FTSE snaps 16-day win streak ahead... 07-May-2025 ShareCast
GSK, AstraZeneca slide after FDA unveils new vac... 07-May-2025 ShareCast
AstraZeneca receives 'positive high-level result... 07-May-2025 ShareCast
AstraZeneca's Calquence gets Europe approval for... 06-May-2025 ShareCast
AstraZeneca's Breztri meets all primary endpoint... 02-May-2025 ShareCast
AstraZeneca reports strong first quarter 29-Apr-2025 ShareCast
AstraZeneca receives positive Phase III trial re... 22-Apr-2025 ShareCast
London close: Stocks fall as China retaliates to... 09-Apr-2025 ShareCast
AstraZeneca's Enhertu gets further EU approval 04-Apr-2025 ShareCast
London close: Stocks slide in global reaction to... 03-Apr-2025 ShareCast
UK pharma stocks avoid selloff 03-Apr-2025 ShareCast
AstraZeneca makes regulatory progress with Imfin... 31-Mar-2025 ShareCast
AstraZeneca spending $2.5bn on new R&D centre, b... 21-Mar-2025 ShareCast
AstraZeneca buys biotech firm Esobiotec for up t... 17-Mar-2025 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,782.00p
Change Today 82.00p
% Change 0.77 %
52 Week High 13,276.00
52 Week Low 9,667.00
Volume 1,034,912
Shares Issued 1,550.66m
Market Cap £167,192m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
93.77% below the market average93.77% below the market average93.77% below the market average93.77% below the market average93.77% below the market average
91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average
Price Trend
17.05% below the market average17.05% below the market average17.05% below the market average17.05% below the market average17.05% below the market average
30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average
Income
61.92% below the market average61.92% below the market average61.92% below the market average61.92% below the market average61.92% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
86.35% above the market average86.35% above the market average86.35% above the market average86.35% above the market average86.35% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 5
Sell 0
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 20-Feb-25 08-Aug-24
Paid 24-Mar-25 09-Sep-24
Amount 210.00¢ 100.00¢

Trades for 06-Jun-2025

Time Volume / Share Price
16:27 0 @ 10,764.00p
16:15 0 @ 10,764.00p
16:08 0 @ 10,756.00p
16:26 14 @ 10,766.00p
16:25 3 @ 10,768.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page